Policy, economics and countermeasures
著者
書誌事項
Policy, economics and countermeasures
(Counterfeit medicines, v. 1)
ILM, 2012
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Although there is some debate about the extent of counterfeits in the world's pharmaceutical supply chain, it is undeniable that counterfeit and substandard medicines are a growing and dangerous business. They can cause major moral, reputational and financial damage to pharmaceutical manufacturers, as well as untold harm to patients who are deceived by the fake version of their medication. This book provides a concise account of the history, policy and law, and financial and economic aspects surrounding pharmaceutical product counterfeiting, as well as some of the countermeasures available to organisations. This valuable publication discusses the problems experienced in lesser developed countries, and reports the activities and findings of governments and agencies around the world. The growth in e-commerce means that the Internet has become the primary tool in the advertisement and sale of counterfeit pharmaceuticals by criminal organisations. The safety concerns regarding illicit online pharmacies are reviewed and an overview is given of the regulatory efforts attempting to stem their negative effects.
The book provides important information on creating an overall anti-counterfeit strategy and a review of current countermeasures, including authentication and tracing programmes. In addition, the book compares some of the problems that have been experienced with those encountered by other product areas in relation to counterfeiting. Important lessons have been learned by other industries, including fine art, wine, diamonds, currency and aeroplane parts. With the inclusion of economic and financial models and projections as well as real-life case studies, this book is essential reading for individuals and organisations affected by this complex issue.
目次
Chapter 1 The Background and History of Counterfeit Medicines Obinna Obi-Eyisi and Albert I. Wertheimer Chapter 2 The Current Policy and Law of Counterfeit Medicines: In Memoriam to Donald Eulette deKieffer, 1945 - 2011 Donald deKieffer and J. Kevin Horgan Chapter 3 The Financial and Economic Aspects of Counterfeit Medicines F. Ellen Loh Chapter 4 The Counterfeiting of Pharmaceutical Products in Lesser Developed Countries: A Case Study of Mexico Rafael Gual Cosio Chapter 5 The Fight Against Counterfeit and Substandard Pharmaceuticals by Governments, International Agencies and Professional Societies Anna Gu Chapter 6 International Politics Becomes Involved in the Fight Against Counterfeit Medicines Kawthar ElBishlawi Chapter 7 Addressing Illicit Online Pharmacies: Global Patient Safety and Regulatory Challenges Bryan A. Liang and Tim Mackey Chapter 8 Counterfeiting in Other Industries: Lessons for Pharmaceuticals Nazli Sencan Chapter 9 Overview of the Selection of Strategic Authentication and Tracing Programmes John Spink
「Nielsen BookData」 より